Multiple roles of matrix metalloproteinases during apoptosis

[1]  M. Diederich,et al.  Modulation of poly(ADP-ribosylation) in apoptotic cells. , 2004, Biochemical pharmacology.

[2]  G. Rosenberg,et al.  Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases , 2004, Apoptosis.

[3]  F. Mannello,et al.  Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis , 2004, Apoptosis.

[4]  H. Maeda,et al.  Proapoptotic Effect of Proteolytic Activation of Matrix Metalloproteinases by Streptococcus pyogenes Thiol Proteinase (Streptococcus Pyrogenic Exotoxin B) , 2004, Infection and Immunity.

[5]  E. Lo,et al.  Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Z. Han,et al.  Signalling mechanisms of anoikis. , 2004, Histology and histopathology.

[7]  J. Nambu,et al.  A fine balance for life and death decisions , 2004, Nature Structural &Molecular Biology.

[8]  P. Galle,et al.  Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells , 2004, Oncogene.

[9]  R. Lockshin,et al.  Caspase-independent cell death? , 2004, Oncogene.

[10]  M. Sung,et al.  Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitro , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Shai Shaham,et al.  Death without caspases, caspases without death. , 2004, Trends in cell biology.

[12]  W. Hornebeck,et al.  An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. , 2004, Critical reviews in oncology/hematology.

[13]  L. Martiny,et al.  Matrix metalloproteinases and matrikines in angiogenesis. , 2004, Critical reviews in oncology/hematology.

[14]  K. Conant,et al.  Matrix Metalloproteinase 1 Interacts with Neuronal Integrins and Stimulates Dephosphorylation of Akt* , 2004, Journal of Biological Chemistry.

[15]  Nastaran Zahir,et al.  Death in the third dimension: apoptosis regulation and tissue architecture. , 2004, Current opinion in genetics & development.

[16]  A. Scovassi,et al.  Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update , 2002, Apoptosis.

[17]  F. Mannello,et al.  Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications , 2001, Apoptosis.

[18]  F. Mannello,et al.  Matrix metalloproteinases expression in HL-60 promyelocytic leukemia cells during apoptosis , 2000, Apoptosis.

[19]  D. Lawrence,et al.  The Low Density Lipoprotein Receptor-related Protein Modulates Protease Activity in the Brain by Mediating the Cellular Internalization of Both Neuroserpin and Neuroserpin-Tissue-type Plasminogen Activator Complexes* , 2003, Journal of Biological Chemistry.

[20]  J. Silke,et al.  Programmed cell death: Superman meets Dr Death , 2003, Nature Cell Biology.

[21]  L. Lund,et al.  MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum , 2003, Molecular and Cellular Neuroscience.

[22]  C. Overall,et al.  HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration , 2003, Nature Neuroscience.

[23]  R. Ransohoff.  Snip-snip, kill-kill: truncated SDF-1 and HIV-associated neurodegeneration , 2003, Nature Neuroscience.

[24]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[25]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[26]  S. Lepreux,et al.  Unexpected localization of the matrix metalloproteinase-3 (MMP-3) within the cell nucleus in liver cancer cells. Mechanisms and consequences , 2003 .

[27]  K. Meerovitch,et al.  A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen , 2003 .

[28]  D. Stump,et al.  401 Hepatitis C virus has a cis-acting replication element in the polymerase gene: a new feature of the HCV genome with implications for drug development , 2003 .

[29]  M. Fini,et al.  Deficiency in Matrix Metalloproteinase Gelatinase B (MMP-9) Protects against Retinal Ganglion Cell Death after Optic Nerve Ligation* , 2002, The Journal of Biological Chemistry.

[30]  L. Matrisian,et al.  Matrix metalloproteinases in tumor-host cell communication. , 2002, Differentiation; research in biological diversity.

[31]  A. Karsan,et al.  Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells , 2002, Cell Death and Differentiation.

[32]  A. Martelli,et al.  The controversial nuclear matrix: a balanced point of view. , 2002, Histology and histopathology.

[33]  D. Green,et al.  Metalloproteinase Shedding of Fas Ligand Regulates β-Amyloid Neurotoxicity , 2002, Current Biology.

[34]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[35]  G. Melino.  The meaning of death , 2002, Cell Death and Differentiation.

[36]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[37]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[38]  D. Green,et al.  A Matter of Life and Death , 2008, Science.

[39]  I. Stamenkovic,et al.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.

[40]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[41]  L. Matrisian,et al.  Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.

[42]  M. Shipp,et al.  Stromelysin‐3 suppresses tumor cell apoptosis in a murine model * , 2001, Journal of cellular biochemistry.

[43]  T. Stricker,et al.  Structural Analysis of the α2 Integrin I Domain/Procollagenase-1 (Matrix Metalloproteinase-1) Interaction* , 2001, The Journal of Biological Chemistry.

[44]  Thiennu H. Vu,et al.  Don't mess with the matrix , 2001, Nature Genetics.

[45]  V. Wee Yong,et al.  Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.

[46]  N. Mitsiades,et al.  Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug , 2001, Expert opinion on investigational drugs.

[47]  C. Sautès-Fridman,et al.  High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. , 2001, Cancer research.

[48]  O. Huber,et al.  Cleavage and Shedding of E-cadherin after Induction of Apoptosis* , 2001, The Journal of Biological Chemistry.

[49]  B. Fingleton,et al.  Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. , 2001, Neoplasia.

[50]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[51]  S. Frisch,et al.  Anoikis mechanisms. , 2001, Current opinion in cell biology.

[52]  I. Stamenkovic,et al.  Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. , 2001, Cancer research.

[53]  B. Sheu,et al.  A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.

[54]  R. Baserga.  The contradictions of the insulin-like growth factor 1 receptor , 2000, Oncogene.

[55]  宮本 洋二.  トランスジェニックマウスを用いたTissue inhibitor of metalloproteinase-1(TIMP-1)の肝線維化過程における役割の解析 , 2000 .

[56]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[57]  Yunbo Shi,et al.  Requirement for Matrix Metalloproteinase Stromelysin-3 in Cell Migration and Apoptosis during Tissue Remodeling in Xenopus laevis , 2000, The Journal of cell biology.

[58]  P. Brown.  Ongoing trials with matrix metalloproteinase inhibitors , 2000, Expert opinion on investigational drugs.

[59]  Thiennu H. Vu,et al.  Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.

[60]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[61]  L. Sjulson,et al.  Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures , 2000, Experimental Neurology.

[62]  C. Cinti,et al.  Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent. , 2006, Scanning.

[63]  B. Fingleton,et al.  The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis , 1999, Current Biology.

[64]  U. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. , 1999, Biochemical and biophysical research communications.

[65]  P. Libby,et al.  Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.

[66]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[67]  R. Ross,et al.  Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. , 1998, Molecular biology of the cell.

[68]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[69]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[70]  J. Cossins,et al.  Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions , 1997, Acta Neuropathologica.

[71]  Jack P. Witty,et al.  Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. , 1995, Cancer research.

[72]  Z. Werb,et al.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.